APA (7th ed.) Citation

KD, O., SK, Q., DR, J., AR, M., R, P., KJ, K., . . . PR, T. (2022). Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core study. Alzheimer's & dementia (New York, N. Y.), 8(1), e12329. https://doi.org/10.1002/trc2.12329

Chicago Style (17th ed.) Citation

KD, Onos, et al. "Pharmacokinetic, Pharmacodynamic, and Transcriptomic Analysis of Chronic Levetiracetam Treatment in 5XFAD Mice: A MODEL-AD Preclinical Testing Core Study." Alzheimer's & Dementia (New York, N. Y.) 8, no. 1 (2022): e12329. https://doi.org/10.1002/trc2.12329.

MLA (9th ed.) Citation

KD, Onos, et al. "Pharmacokinetic, Pharmacodynamic, and Transcriptomic Analysis of Chronic Levetiracetam Treatment in 5XFAD Mice: A MODEL-AD Preclinical Testing Core Study." Alzheimer's & Dementia (New York, N. Y.), vol. 8, no. 1, 2022, p. e12329, https://doi.org/10.1002/trc2.12329.